scholarly journals Alpelisib: A Well-Tolerated Treatment Option for Patients with HR-Positive, HER2-Negative PIK3CA-Mutated Advanced Breast Cancer

2021 ◽  
Author(s):  
Fei-Yu Diao
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Treatment Option ◽  
Advanced Breast

scholarly journals Entinostat: a promising treatment option for patients with advanced breast cancer

2017 ◽  
Vol 13 (13) ◽  
pp. 1137-1148 ◽  
Author(s):  
Roisin M Connolly ◽  
Michelle A Rudek ◽  
Richard Piekarz
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Treatment Option ◽  
Advanced Breast ◽  
Promising Treatment

Gemcitabine, epirubicin, and paclitaxel combinations in advanced breast cancer

2001 ◽  
Vol 28 (2D) ◽  
pp. 15-17
Author(s):  
PierFranco Conte ◽  
Barbara Salvadori ◽  
Sara Donati ◽  
Elisabetta Landucci ◽  
Alessandra Gennari
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast

New cytotoxic agents and schedules for advanced breast cancer

2001 ◽  
Vol 28 (4) ◽  
pp. 344-358 ◽  
Author(s):  
Harold J. Burstein ◽  
Craig A. Bunnell ◽  
Eric P. Winer
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Cytotoxic Agents
Sign in / Sign up

Export Citation Format

Share Document